Podcast Q&A: EU HTA Joint Clinical Assessments
In this episode of tHEORetically Speaking, join Dr. Rosemary Jose, Dr. Sonja Kroep, and Nick Halfpenny from OPEN Health, Dr. Ansgar Hebborn from Roche, and James Ryan from AstraZeneca, who answer questions from a recent webinar on several policy aspects regarding the current challenges and implications of the EU Health Technology Assessment (HTA) regulation.
For more information, to watch the webinar, or access other resources, click here.
Associated Webinar: EU HTA Joint Clinical Assessments: Navigating Potential Challenges Ahead of 2025
Similar Podcasts
Podcast Q&A: Discussing Health Technology Assessment Agencies
Join industry experts as they answer questions on what Health Technology Assessment (HTA) agencies do and the types of literature reviews they do.
Podcast Q&A: Improving Health Literacy
Experts dicuss how to improve health literacy and the understandability of the HEOR process to enable effective partnerships, as well as to assist patients to participate in shared decision making with their physicians.
Additional Content From OPEN Health
Integrated Evidence Generation Planning: Driving Successful Reimbursement and Life Cycle Management
Hear four panelists discuss the role of integrated evidence generation in healthcare, focusing on its impact on patient outcomes and healthcare decision-making.
EU HTA Joint Clinical Assessments: Navigating Potential Challenges Ahead of 2025
This panel discusses several policy aspects regarding the current challenges and implications of the EU Health Technology Assessment (HTA) regulation.
Making HEOR More Accessible to Patients
Join this panel discussion to hear experts from patient advocacy, health literacy, and Health Economics and Outcomes Research (HEOR).